InvestorsHub Logo
Followers 2
Posts 189
Boards Moderated 0
Alias Born 04/28/2017

Re: jdlamont post# 15

Thursday, 03/29/2018 5:52:27 AM

Thursday, March 29, 2018 5:52:27 AM

Post# of 200
If you are going to make statements you should read everything on the company.
Dilution was 10%. There are a total of 220mio equivalent ASX shares; This is all ASX ordinary shares, all ASX IMCOB options, all Nasdaq IMRN ADR's at 40:1 and all Nasdaq IMRNW warrants & the new issuance at 39 cents with attaching options.
So at USD$250mio market cap, or ~$1.45/$1.50 ASX or IMRN $45, then Immuron is an acceptable starting valuation. Even though Big pharma will likely pay USD$500mio-$1bio right now for the whole company, pipeline in Cdiff, NASH, ASH, travelan etc.
I am very happy with my ASX longs, ASX options & my IMRNW warrants.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IMRN News